LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat...( LegalView re...),Health

LegalView recently posted detailed information on its Cimzia information portal regarding the potentially serious side effects caused by the drug and its family known as TNF inhibitors. Among the drug's potential side effects are the development of fatal infections and cancer-causing agents for young adult and child patients.

Denver, CO (PRWEB) October 6, 2008 -- LegalView, the number one resource for everything and anything legal on the Internet, informed arthritis and Crohn's disease patients about the potentially fatal dangers posed by a group of prescription drugs known as TNF blockers. The drugs, which include Cimzia, Humira, Enbrel and Remicade, are all categorized as tumor necrosis factor (TNF) inhibitors that act as immunosuppressors to decrease the pain in patients suffering from rheumatoid or juvenile arthritis as well as Crohn's disease, which is a severe inflammation of the gastrointestinal (GI) tract.

One of the TNF blockers is the drug known as Remicade (infliximabe) from Johnson & Johnson, which was approved in 1999. The drug treats psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, sarcoidosis and ulcerative colitis. The potential http://remicade.legalview.com [Remicade side effects __title__ Remicade Risks] associated with taking the drug can include the development of blood disorders (some of which have been deemed fatal) allergic reactions, reactivation of hepatitis B and the potential for developing lymphoma, according to the company.

Humira, from Abbott Laboratories, was introduced for use only a few years ago in 2002. Patients taking Humira -- also approved to treat rheumatoid/psoriatic arthritis, Crohn's disease, psoriasis, ankylosing spondylitis and juvenile idiopathic arthritis -- should speak to a medical professional immediately if they are showing any signs of the potential http://humira.legalview.com [Humir
'/>"/>